Time to speed up scientific deliveries in fibrotic interstitial lung disease: innovative clinical trial design to improve patient care by Kawano-Dourado, L, Kulkarni, T, Ryerson, CJ, Richards, DB

Current usage of explainer animations in trials: a survey of the UKCRC registered clinical trial units in the UK by Barber, VS, Calvert, C, Appelbe, D, Sprange, K, Nollett, C, Tanner, S, Richards, DB

Developing generic clinical trial animated explainer videos in the UK: results of a survey and case study by Calvert, C, Barber, VS, Appelbe, D, Sprange, K, Nollett, C, Lugg-Widger, F, Tanner, S, Richards, DB

Use of oxygen-loaded nanobubbles to improve tissue oxygenation: bone-relevant mechanisms of action and effects on osteoclast differentiation by Knowles, HJ, Vasilyeva, A, Sheth, M, Pattinson, O, May, J, Rumney, RMH, Hulley, PA, Richards, DB, Carugo, D, Evans, ND, Stride, E

Opioid antagonists and the A118G polymorphism in the μ-opioid receptor gene: effects of GSK1521498 and naltrexone in healthy drinkers stratified by OPRM1 genotype by Ziauddeen, H, Nestor, LJ, Subramaniam, N, Dodds, C, Nathan, PJ, Miller, SR, Sarai, BK, Maltby, K, Fernando, D, Warren, L, Hosking, LK, Waterworth, D, Korzeniowska, A, Win, B, Richards, DB, Johnson, L, Fletcher, PC, Bullmore, ET

Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial by Dorward, J, Yu, L-M, Hayward, G, Saville, B, Gbinigie, OA, van Hecke, O, Ogburn, E, Evans, PH, Thomas, N, Patel, M, Richards, DB, Berry, N, Saunders, CT, Detry, MA, Fitzgerald, M, Harris, V, Shanyinde, M, de Lusignan, S, Andersson, MI, Butler, CC, Hobbs, FDR

Cost-utility analysis of molnupiravir plus usual care versus usual care alone as early treatment for community-based adults with COVID-19 and increased risk of adverse outcomes in... by Png, ME, Harris, V, Grabey, J, Hart, ND, Jani, BD, Butler, D, Carson-Stevens, A, Coates, M, Cureton, L, Dobson, M, Dorward, J, Evans, P, Francis, N, Gbinigie, OA, Hayward, G, Holmes, J, Hood, K, Khoo, S, Ahmed, H, Lown, M, McKenna, M, Mort, S, Nguyen-Van-Tam, J, Rahman, N, Richards, DB, Thomas, N, van Hecke, O, Hobbs, FR, Little, P, Yu, L-M, Butler, CC, Petrou, S

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients by Standing, JF, Buggiotti, L, Guerra-Assuncao, JA, Woodall, M, Ellis, S, Agyeman, AA, Miller, C, Okechukwu, M, Kirkpatrick, E, Jacobs, AI, Williams, CA, Roy, S, Martin-Bernal, LM, Williams, R, Smith, CM, Sanderson, T, Ashford, FB, Emmanuel, B, Afzal, ZM, Shields, A, Richter, AG, Dorward, J, Gbinigie, O, Van Hecke, O, Lown, M, Francis, N, Jani, B, Richards, DB, Rahman, NM, Yu, L-M, Thomas, NPB, Hart, ND, Evans, P, Andersson, M, Hayward, G, Hood, K, Nguyen-Van-Tam, JS, Little, P, Hobbs, FDR, Khoo, S, Butler, C, Lowe, DM, Breuer, J, Allen, J, Bayzid, N, Brown, J, Burns, D, Hadley, E, Hatcher, J, McHugh, T

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive... by Butler, CC, Hobbs, FDR, Gbinigie, OA, Rahman, NM, Hayward, G, Richards, DB, Dorward, J, Lowe, DM, Standing, JF, Breuer, J, Khoo, S, Petrou, S, Hood, K, Nguyen-Van-Tam, JS, Patel, MG, Saville, BR, Marion, J, Ogburn, E, Allen, J, Rutter, H, Francis, N, Thomas, NPB, Evans, P, Dobson, M, Madden, T-A, Holmes, J, Harris, V, Png, ME, Lown, M, van Hecke, O, Detry, MA, Saunders, CT, Fitzgerald, M, Berry, NS, Mwandigha, L, Galal, U, Mort, S, Jani, BD, Hart, ND, Ahmed, H, Butler, D, McKenna, M, Chalk, J, Lavallee, L, Hadley, E, Cureton, L, Benysek, M, Andersson, M, Coates, M, Barrett, S, Bateman, C, Davies, JC, Raymundo-Wood, I, Ustianowski, A, Carson-Stevens, A, Yu, L-M, Little, P